(Q38286491)
Statements
Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review (English)
Ning Zhao
Shu-yi Zheng
Jin-ji Yang
Xu-chao Zhang
Zhi Xie
Bin Xie
Jian Su
Zhi-hong Chen
Shi-liang Chen
Na Zhang
Na-na Lou
18 November 2014